␤-Lactamases inactivate penicillin and cephalosporin antibiotics by hydrolysis of the ␤-lactam ring and are an important mechanism of resistance for many bacterial pathogens. Four wild-type variants of Staphylococcus aureus ␤-lactamase, designated A, B, C, and D, have been identified. Although distinguishable kinetically, they differ in primary structure by only a few amino acids. Using the reported sequences of the A, C, and D enzymes along with crystallographic data about the structure of the type A enzyme to identify amino acid differences located close to the active site, we hypothesized that these differences might explain the kinetic heterogeneity of the wild-type ␤-lactamases. To test this hypothesis, genes encoding the type A, C, and D ␤-lactamases were modified by site-directed mutagenesis, yielding mutant enzymes with single amino acid substitutions. The substitution of asparagine for serine at residue 216 of type A ␤-lactamase resulted in a kinetic profile indistinguishable from that of type C ␤-lactamase, whereas the substitution of serine for asparagine at the same site in the type C enzyme produced a kinetic type A mutant. Similar bidirectional substitutions identified the threonine-to-alanine difference at residue 128 as being responsible for the kinetic differences between the type A and D enzymes. Neither residue 216 nor 128 has previously been shown to be kinetically important among serine-active-site ␤-lactamases.
␤-Lactam antibiotics, including the penicillins and cephalosporins, are important agents in the therapy of bacterial infections. However, in some clinical settings the usefulness of these agents has been diminished by the emergence and spread of bacterial strains that produce ␤-lactamase, which hydrolyzes the ␤-lactam ring and inactivates the drug's antimicrobial effect (27) . This problem has been demonstrated most dramatically with Staphylococcus aureus. Whereas the vast majority of clinical isolates of S. aureus were highly susceptible to penicillin G at the time of its introduction into clinical use in the early 1940s, the spread of ␤-lactamase-producing, penicillin-resistant strains was so widespread by the late 1940s that penicillin G was no longer a reliable antistaphylococcal agent. Most clinical isolates of S. aureus produce ␤-lactamase (36) .
Four types of S. aureus ␤-lactamase have been identified by serologic (34, 35) and kinetic (19, 20) methods. These variants originally were designated types A, B, C, and D by Richmond (34) and Rosdahl (35) . This nomenclature should not be confused with that of the different classes of ␤-lactamases, A through D, that has been used more recently to group the ␤-lactamases of all bacterial species on the basis of active site (serine versus zinc), size, and kinetic characteristics (4) . Each of the four recognized types of S. aureus ␤-lactamase (A, B, C, and D) is a class A ␤-lactamase with a serine active site. The mature form of the enzyme has a molecular mass of 30 kDa, contains 257 amino acids, and is excreted extracellularly (1) .
The type A and C staphylococcal ␤-lactamases are easily distinguished kinetically, either by substrate profile (18) or by K m and catalytic constant (k cat ) determinations (43) . Whereas the kinetics of hydrolysis exhibited by the type A and D staphylococcal ␤-lactamases are similar (20) , they can be rapidly and reproducibly distinguished by a fivefold difference in the ratio of the rates of the initial velocity of hydrolysis of penicillin G and cefazolin (43) . The lower penicillin G/cefazolin hydrolysis ratio of the type D ␤-lactamase appears to be related to a lower k cat for the hydrolysis of penicillin G by purified type D enzyme than the other staphylococcal ␤-lactamases (43) .
The genes encoding the type A, C, and D ␤-lactamases of S. aureus are located on plasmids and have been cloned and sequenced (5, 8, 9, 40) . The deduced amino acid sequences identify six amino acid differences in the primary sequence of the prototypic type A ␤-lactamase from strains PC1 and S1 compared with the type C sequence from strain 3804, including amino acids 116, 202, 205, 206, 212, and 216. In addition, there are five differences, at amino acids 93, 121, 128, 226, and 229, between the prototypic type A ␤-lactamase and the type D ␤-lactamase produced by strain FAR4. The type C and D enzymes differ by 11 amino acids.
The molecular basis for the kinetic heterogeneity exhibited by the staphylococcal ␤-lactamases has not been determined. However, the structure of the type A variant of S. aureus ␤-lactamase is known from X-ray crystallographic analysis (11, 12) , and several of the amino acids which are different between the type A, C, and D ␤-lactamases are located close to the active-site cleft. To test the hypothesis that single amino acid differences at sites close to the active site are responsible for the kinetic heterogeneity exhibited by naturally occurring variants of S. aureus ␤-lactamase, we constructed mutant ␤-lactamases with single amino acid substitutions at sites where the wild-type enzymes differ and evaluated the kinetics of the mutant enzyme.
containing the type A, C, and D blaZ genes were cloned individually into the phage vector M13mp18 (42) . Two oligonucleotides, each with a single mismatch (underlined), were used to introduce specific mutations at amino acids 128 (5ЈTCACTATATGCCATTGAAGCC3Ј; Thr to Ala) and 216 (5ЈAGTATCTC CGTTTTTATTATT3Ј; Ser to Asn) of the type A blaZ. Additional primers were constructed to produce the reverse mutation in the type C and D blaZ genes (i.e., 5ЈAGTGTCTCCGCTTTTATTATT, Asn to Ser, type C blaZ and 5ЈATCACT ATATGTCATTGAAGC, Ala to Thr, type D blaZ). Single-stranded DNA from the six randomly picked plaques was sequenced by the dideoxy chain termination method (38) using Sequenase enzyme to confirm the desired mutation. The complete open reading frame was sequenced in order to rule out the presence of any spurious mutations.
Expression of wild-type and mutant ␤-lactamases in S. aureus RN4220. Wildtype blaZ encoding type A, C, and D ␤-lactamases and mutant blaZ genes from M13mp18 recombinants were cloned as 1.1-to 1.8-kb HindIII fragments into the HindIII site of S. aureus-E. coli shuttle plasmid pVK101. Recombinants were selected on LB medium containing ampicillin (100 g/ml) and chloramphenicol (30 g/ml). The desired orientation of the insert was verified either by restriction with EcoRV, which has a single site within type A and D blaZ and one just upstream of the blaZ promoter within blaR, or by PCR. Protoplast transformation was used to transfer the recombinant shuttle plasmids into S. aureus RN4220 (6).
␤-Lactamase purification from S. aureus. The wild-type ␤-lactamase-producing strains and the RN4220 transformants were grown in 5 liters of modified 1% CY medium containing methicillin (0.5 g/ml) or 2-(2Ј-carboxyphenyl)benzoyl-6-aminopenicillanic acid (7.5 M, to induce ␤-lactamase production) at 37ЊC and 150 rpm for 18 h. The extracellular ␤-lactamases were purified by sequential cation-exchange and affinity chromatography (21) .
Enzyme kinetics. Initial velocities of hydrolysis were monitored at a wavelength corresponding to the maximal change in absorbance between the unhydrolyzed substrate and the hydrolyzed product, which included the following: cephaloridine, 254 nm; cefazolin, 272 nm; nitrocefin, 482 nm; cephapirin, 258 nm; ampicillin, 235 nm; and penicillin G, 232 nm (37, 39) . ␤-Lactamase assays were performed in 0.1 M sodium phosphate buffer, pH 6.0, in 1-cm cuvettes at 37ЊC with a DU-70 recording spectrophotometer (Beckman Instruments, Fullerton, Calif.). For K m and k cat determinations, assays of the initial velocity of hydrolysis were performed using 100, 50, 33. 
RESULTS
Construction and expression of mutant ␤-lactamases. The primary goal of this study was to determine the functional domains, particularly the specific amino acid(s), responsible for the kinetic heterogeneity observed among naturally occurring variants of S. aureus ␤-lactamase. Mutant ␤-lactamases with single amino acid substitutions at residues 128 (Thr to Ala) and 216 (Ser to Asn) were constructed by using oligonucleotide-directed mutagenesis and the type A ␤-lactamase gene (blaZ) as a template. In addition, the reverse mutations were introduced by using the type D (Ala to Thr, residue 128) and type C (Asn to Ser, residue 216) blaZ genes as template DNA. These residues were selected primarily because of the amino acids which differed among the type A, C, and D ␤-lactamases, 128 and 216 were closest to the active-site cleft (Fig.  1) . Each blaZ was cloned into E. coli-S. aureus shuttle plasmid pVK101, which was then transformed into S. aureus RN4220. ␤-Lactamase production was induced, and the wild-type ␤-lactamases expressed by the reference strains and the mutant enzymes expressed in RN4220 were purified to homogeneity.
Effect of substitution at amino acid 216 on the kinetics of type A and C ␤-lactamases. ␤-Lactams which have been shown previously to be useful in distinguishing between the wild-type S. aureus ␤-lactamases (20) were used to compare the kinetics of hydrolysis of the reference and mutant enzymes (Tables 2  and 3 ). Between the type A and type C ␤-lactamases there were a 10-fold difference in the K m values of cefazolin, a 5-fold difference in the K m values of cephapirin, and a 5-fold difference in the k cat values of nitrocefin. These differences appear to be due to whether Ser or Asn was present at residue 216. Replacement of Ser by Asn in the type A ␤-lactamase yielded a mutant (A, S216N) that was closer kinetically to the type C than the type A enzyme (e.g., cefazolin K m values: 167 M, mutant; 145 M, type C; 13.1 M, type A). The reverse mutation using type C blaZ DNA for site-directed mutagenesis yielded a mutant (C, N216S) that was similar to the type A enzyme (cefazolin K m value, 15.3 M). Also, the differences between the kinetic type A and type C S. aureus ␤-lactamases are clearly shown by comparing relative efficiency of hydrolysis values ( Table 4 ). The k cat values of most substrates other than nitrocefin did not clearly distinguish between the type A and type C enzymes ( Table 3) .
Effect of substitution at amino acid 128 on the kinetics of type A and D ␤-lactamases. The reference type A ␤-lactamase had a cefazolin K m value that was threefold lower than and an ampicillin K m value that was twofold greater than the respective K m values of the type D enzyme. In addition, the k cat values of ampicillin and penicillin G were three-to fourfold higher with the type A compared to the type D ␤-lactamase. These differences were related to whether Ala or Thr was present at residue 128. Replacement of Thr by Ala in the type A ␤-lactamase yielded a mutant (A, T128A) that was closer kinetically to the type D than the type A enzyme (e. (Table  5) .
DISCUSSION
Naturally occurring variants of S. aureus ␤-lactamase can be distinguished on the basis of the kinetics of hydrolysis of selected penicillin and cephalosporin antibiotics (20, 43) . In this study we have shown that these kinetic differences are determined by single amino acid substitutions at positions close to the active site of the enzyme. Specifically, the presence of an Asn instead of Ser at residue 216 determines a type C kinetic profile, and the presence of an Ala instead of Thr at residue 128 determines a type D kinetic profile. Enzymes exhibiting the type A kinetic profile have Ser and Thr at these two sites, respectively. We also found that substitutions at some positions other than 128 and 216 where the type A, C, and D enzymes have different amino acids did not alter the kinetic profile of the enzyme (e.g., amino acid 121 [data not shown]).
This situation is reminiscent of what has been reported for the newer TEM-type ␤-lactamases and SHV ␤-lactamase variants among gram-negative bacterial species (17) . Broad-spectrum TEM and SHV variant ␤-lactamases capable of hydrolyzing ceftazidime, cefotaxime, and/or other newer cephalosporins have become problematic in many medical centers in recent years, especially among isolates of Klebsiella pneumoniae and E. coli (14, 17, 31) . As with the S. aureus enzymes, the altered kinetic profile of the broad-spectrum TEM-type ␤-lactamases is based on modest changes in primary structure, generally one to three amino acid substitutions at sites close to the active site (32) . In addition, single mutations that result in TEM and SHV variant ␤-lactamases exhibiting resistance to commercially available ␤-lactamase inhibitors such as clavulanic acid have been described (7, 15) .
A major difference between the histories of the variant TEM and staphylococcal enzymes, however, is that whereas the former appear to be a consequence of selective antibiotic pressure in the clinical setting, the S. aureus enzymes appear to have remained remarkably stable over time. Although ␤-lactamase-producing strains of S. aureus spread widely during the first few years following the clinical introduction of penicillin, some clinical isolates collected and saved prior to penicillin use have been shown to produce the A and C variants of S. aureus ␤-lactamase. Furthermore, the prevalence of the various types of staphylococcal ␤-lactamases among clinical isolates in the United States in the 1980s (19, 20) are similar to what was reported in England by Richmond in the mid-1960s when he first described the existence of different staphylococcal ␤-lactamase serotypes (34) . Despite the widespread use since the early 1960s of antistaphylococcal penicillins such as methicillin, oxacillin, and nafcillin, new staphylococcal ␤-lactamases capable of hydrolyzing these agents efficiently have not been observed.
Both of the amino acid positions that we have shown to be responsible for the kinetic differences among the wild-type S. aureus enzymes have not previously been cited as contributing to ␤-lactamase function. The major kinetic difference between the type A and C enzymes is the K m values of certain cepha- 2 nm]) and may be hindering the substrate binding into the active-site cleft. Modelling studies with cefazolin docked into the PC1 ␤-lactamase active-site cleft show that the side chain C 3 substituent in cefazolin is positioned close to side chain of Ser-216 (unpublished observations) and substitution of Asn for Ser at this position would result in steric hindrance. Second, the refined crystal structure of PC1 ␤-lactamase at 2 Å (0.2 nm) indicated that the amino acid 216 is located on a short 3 10 helix comprising amino acids 215 to 217 and this helix is stabilized through a helix N capping (33) between Asn-214, which is highly conserved among class A ␤-lactamases (2), and Ser-216 (O-N, 2.9 Å [0.29 nm]). In addition to this, the side chain OH of Ser-216 is also involved in a hydrogen bond with Asn-214 side chain carbonyl (O-O, 3.3 Å [0.33 nm]). Substitution of Asn for Ser at 216 may alter the topology of this short helix. The crystal structure of a type C enzyme could help to clarify the structure of this loop, and attempts are under way to crystallize the type C enzyme. Third, amino acid 216 is located close to the ␤3 strand, and changes at this residue might alter the relative positioning of other active-site amino acids such as the K-T-G triad.
The reason why the replacement of Thr by Ala at residue 128 should affect enzyme function is less clear. The effect of the substitution was primarily a reduction in the k cat of the penicillins and nitrocefin along with modest effects on the K m values of cefazolin and ampicillin ( Table 2 ). The crystal structure of PC1 indicates that amino acid 128 is located at the C terminus of ␣-helix 4 close to the active-site cleft. It is two residues away from the highly conserved S-D-N loop (amino acids 130 to 132) of the class A ␤-lactamases. The catalytic function of the S-D-N loop has been verified by site-directed mutagenesis of Streptomyces albus G ␤-lactamase (16) and E. coli TEM ␤-lactamase (30) . The proximity of amino acid 128 to the catalytically important S-D-N loop might explain the kinetic differences between the type A and type D S. aureus ␤-lactamases. Preliminary experiments in which residue 128 has been replaced by other amino acids also have been shown to affect the kinetics of hydrolysis (unpublished observations).
In conclusion, naturally occurring type A, C, and D variants of S. aureus ␤-lactamase exhibit kinetic differences due to single amino acid differences at positions close to the active site which have not previously been shown to be involved in enzymatic activity. It is likely that the substitution at the amino acid 128 affects enzyme function by altering the structure of catalytically important S-D-N loop. The differences between the type A and type C enzyme could be due to steric hindrance to substrate binding and/or some structural stabilization effects. This has to be verified by kinetic studies with mutant enzymes in which amino acids 128 and 216 are substituted with different amino acids as well as molecular modelling studies with different ␤-lactam substrates. 
